LIXT - Lixte Biotechnology Holdings Inc

Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets related to serious common diseases and designs novel compounds to attack those targets. The company is headquartered in East Setauket, New York.

52W High

$5.14

52W Low

$0.64

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.48

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.50

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

32.00

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

10.85%

Institutions (25–75% balanced)

6.34%

Shares Outstanding

4,561,400

Float

4,267,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-1.28

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-2.13%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.5075

0.3823

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025